Lumiera Health Inc. (NHPHF)
Lumiera Health Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Saint-Hubert, QC, CA. The stock last traded at $0.02, up 0.00% on the session, giving a market capitalisation of $3.0M. Its beta of 1.09 implies it has historically moved more than the broad market.
Lumiera Health Inc., encompassing its various subsidiaries, operates within the Canadian healthcare sector, developing and commercializing scientifically-backed botanical products. The company's portfolio includes both oral and topical botanical agents designed to address unmet medical needs, particularly in sleep assistance and pain management. Specifically, the company's Holizen brand offers a range of herbal tonics and supplements targeting cardiovascular well-being, stress reduction, enhanced bone, joint, and muscle mobility, as well as energy and immune support. For sleep solutions, Lumiera markets products under its Bazzzics brand, while its Awaye brand provides a dedicated pain relief cream. Lumiera Health Inc. maintains its corporate headquarters in Saint-Hubert, Canada.
Lumiera Health Inc. is most often compared with the following Healthcare names: